AKM-66863-15925
4 vaccinations
6 coded responses
39 check-ins
6 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 761 / TX
- Registered
- 2020-12-24
- Relationship
- Self
- Race
- Asian
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-24
Registered in v-safe
-
2020-12-24
Dose 1 — Pfizer-BioNTech
- 2020-12-24
- 2020-12-25
- 2020-12-26
- 2020-12-27
- 2020-12-29
- 2020-12-30
- 2020-12-31
- 2021-01-07
-
2021-01-14
Dose 2 — Pfizer-BioNTech
- 2021-01-14
- 2021-01-15
-
2021-01-16
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy — Feeling: Fair · Site: Pain · Fever · Chills, HeadacheFree text: LymphadenopathyMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-17
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy — Feeling: Good · Site: PainFree text: LymphadenopathyMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-18
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy — Feeling: Good · Site: PainFree text: LymphadenopathyMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-20
- 2021-01-23
- 2021-01-28
- 2021-02-04
- 2021-02-11
- 2021-02-18
- 2021-02-25
- 2021-04-15
- 2021-07-15
-
2021-09-15
Dose 3 — Pfizer-BioNTech
- 2021-09-29
- 2021-10-06
- 2021-10-13
- 2021-10-20
- 2021-10-27
- 2021-12-15
- 2022-03-16
-
2022-09-17
Dose 4 — Moderna
- 2022-09-17
- 2022-09-17
-
2022-09-18
Survey response — days 1–6 daily, dose 4MedDRA: Lymphadenopathy — Feeling: Poor · Site: Pain · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Lymph node swollenMedDRA releases: 2024-11 · check-in free text available
-
2022-09-19
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain · Fever · Chills, Headache, Fatigue or tirednessAdult check-in
-
2022-09-20
Survey response — days 1–6 daily, dose 4MedDRA: Lymphadenopathy — Feeling: Good · Site: PainFree text: LymphadenopathyMedDRA releases: 2024-11 · check-in free text available
-
2022-09-21
Survey response — days 1–6 daily, dose 4MedDRA: Lymphadenopathy — Feeling: Good · Site: PainFree text: LymphadenopathyMedDRA releases: 2024-11 · check-in free text available
- 2022-09-22
- 2022-09-26
- 2022-10-03
- 2022-10-08
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-24 | Pfizer-BioNTech | |
| 2 | 2021-01-14 | Pfizer-BioNTech | |
| 3 | 2021-09-15 | Pfizer-BioNTech | No |
| 4 | 2022-09-17 | Moderna | No |
Free text
Release 2 — days 1–6 daily, dose 2
Systemic reaction (other): Lymphadenopathy
Systemic reaction (other): Lymphadenopathy
Systemic reaction (other): Lymphadenopathy
Release 12 — days 1–6 daily, dose 4
Systemic reaction (other): Lymph node swollen
Systemic reaction (other): Lymphadenopathy
Systemic reaction (other): Lymphadenopathy
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Lymphadenopathy | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release